La « synergie phages-antibiotiques » - Un enjeu pour la phagothérapie
Med Sci (Paris), 24 5 (2008) 449-451
Published online: 2008-05-15
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Characterization and phage-antibiotic synergy of bacteriophages PES-1 and PES-2 against porcine enterotoxigenic Escherichia coli
Tingfang Li, Lina Fu, Jiansong You, Fazal Mehmood Khan, Jianguang Li, Yanfen Liu, Xiaoyu Li, Yongping Xu and Lili WangFrontiers in Microbiology 17 (2026)
https://doi.org/10.3389/fmicb.2026.1713167
A new approach to overcoming antibiotic-resistant bacteria: Traditional Chinese medicine therapy based on the gut microbiota
Peng Xue, Rui Sang, Nan Li, et al.Frontiers in Cellular and Infection Microbiology 13 (2023)
https://doi.org/10.3389/fcimb.2023.1119037
https://doi.org/10.1016/bs.pmbts.2023.03.018
The Lytic Activity of Bacteriophage ZCSE9 against Salmonella enterica and Its Synergistic Effects with Kanamycin
Abdallah S. Abdelsattar, Mohamed Atef Eita, Zainab K. Hammouda, et al.Viruses 15 (4) 912 (2023)
https://doi.org/10.3390/v15040912
Siphoviridae bacteriophage treatment to reduce abundance and antibiotic resistance of Pseudomonas aeruginosa in wastewater
E. Grami, N. Salhi, K. S. Sealey, et al.International Journal of Environmental Science and Technology 19 (4) 3145 (2022)
https://doi.org/10.1007/s13762-021-03366-3
Synergistic Effects of Bacteriophage vB_Eco4-M7 and Selected Antibiotics on the Biofilm Formed by Shiga Toxin-Producing Escherichia coli
Agnieszka Necel, Sylwia Bloch, Gracja Topka-Bielecka, et al.Antibiotics 11 (6) 712 (2022)
https://doi.org/10.3390/antibiotics11060712
MDR Pumps as Crossroads of Resistance: Antibiotics and Bacteriophages
Pavel A. NazarovAntibiotics 11 (6) 734 (2022)
https://doi.org/10.3390/antibiotics11060734
Bacteriophages: Protagonists of a Post-Antibiotic Era
Pilar Domingo-Calap and Jennifer Delgado-MartínezAntibiotics 7 (3) 66 (2018)
https://doi.org/10.3390/antibiotics7030066
Characterization of novelStaphylococcus aureuslytic phage and defining their combinatorial virulence using the OmniLog® system
Luis A. Estrella, Javier Quinones, Matthew Henry, et al.Bacteriophage 6 (3) e1219440 (2016)
https://doi.org/10.1080/21597081.2016.1219440
Qu’est-ce que la phagothérapie ?
Alain DublanchetHegel N° 4 (4) 354 (2014)
https://doi.org/10.3917/heg.044.0354
Qu’est-ce que la phagothérapie ?
Alain DublanchetHegel N° 4 (4) 354 (2014)
https://doi.org/10.4267/2042/54390
Phage therapy
John N. Housby and Nicholas H. MannDrug Discovery Today 14 (11-12) 536 (2009)
https://doi.org/10.1016/j.drudis.2009.03.006
La phagothérapie au XXIe siècle. Première partie : que pourrait-elle apporter aujourd’hui ?
A. DublanchetAntibiotiques 10 (4) 209 (2008)
https://doi.org/10.1016/j.antib.2008.08.002